All News

In all aspects of healthcare, we must be able to listen to, and keep confidential, anything that a patient shares, in whatever form it comes. By the same token, we must be able to communicate frankly and openly with patients conveying the necessary message.

To get ready, we are teasing each challenge and how it has affected the healthcare industry. Read on to find out how physicians have been struggling to manage patient satisfaction, and lack thereof, this year.

We are teasing each challenge and how it has affected the healthcare industry. Read on to find out how physicians have been struggling this year to remain independent in the face of value-based care initiatives

I was recently inspired by another article in Medical Economics, and curiously, have a solution for each legitimate gripe, based on decades of sorting through the combatants in this health-care disaster we’re engaged in on a daily basis.

For the fifth consecutive year, Medical Economics will reveal its list of obstacles physicians say they face in the coming year and, more importantly, how to overcome them. As we did last year, we asked readers to tell us what challenges they face each day and where they need solutions.

We've all heard the outrage over the sudden rise in the price of the EpiPen. What we hear far less often is how common the sudden and dramatic rise in many other pharmaceutical prices has become in recent years. It can be easy to forget issues like this until they affect us personally.

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) is not going to hold down the increasing cost of Medicare by adding over 1,600 pages of new regulations to the program. Instead, the Centers for Medicare & Medicaid Services (CMS) should have reduced the cost of traditional Medicare by eliminating the requirement for detailed documentation of evaluation and management (E/M) charges.